Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Endometrial Neoplasms × Megestrol Acetate × Clear all

Phase

Phase 2 8 Phase 2/3 3 Phase NA 2 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1

Interventions

pembrolizumab 20 Paclitaxel 13 Carboplatin 13 temsirolimus 6 Trastuzumab 6 Taxes 6 Radiotherapy 5 Topotecan 4 Specimen Handling 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 Docetaxel 4 Cisplatin 4 Biopsy 4 Bevacizumab 4 lenvatinib 3 dostarlimab 3 atezolizumab 3 Sirolimus 3 Pemetrexed 3 Irinotecan 3 Gemcitabine 3 Fulvestrant 3 Cetuximab 3 spartalizumab 2 olaparib 2 fludarabine 2 durvalumab 2 ceralasertib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05332483 2023-11-03

MA-EEC

Sunnybrook Health Sciences Centre

Phase 1 Terminated

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡